Clinical Trials Browser

Phase 2 × INDUSTRY × secukinumab × Clear all

NCT00584740 2015-03-31

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

Phase 2 Terminated

59 enrolled 13 charts

Crohn Disease, Lymphoma, Follicular, Motor Activity